SR9009 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
Well-being is what is intrinsically good for a person. Also called welfare and quality of life, it is a measure of how well life is going for someone. In the broadest sense, it covers the balance of all positive and negative aspects of a person's life. More narrowly, it refers only to positive degrees and contrasts with ill-being, which denotes negative ones. In this sense, well-being is what egoists typically seek for themselves and altruists aim to enhance in others, serving as a central goal of many individual and societal endeavors. Researchers discuss different types of well-being by how they are measured, who they belong to, and which domain of life they affect. Subjective well-being refers to how a person feels about and evaluates their life. Objective well-being encompasses factors that can be assessed from an external perspective, such as health, income, and security. Individual well-being concerns the quality of life of a particular person, whereas community well-being measures how well a group of people functions and thrives. Forms of well-being belonging to specific domains of life include physical, psychological, emotional, social, and economic well-being. Theories of well-being aim to identify its essential features. Hedonism argues that well-being ultimately depends on the balance of pleasure over pain. Desire theories hold that the satisfaction of desires is the source of well-being. Objective list theories assert that a combination of diverse elements is responsible for well-being.
Insulin ( ; from Latin insula 'island') is a peptide hormone produced by beta cells of the pancreatic islets encoded in humans by the insulin (INS) gene. It is the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats, and protein by promoting the absorption of glucose from the blood into cells of the liver, fat, and skeletal muscles. In these tissues the absorbed glucose is converted into either glycogen, via glycogenesis, or fats (triglycerides), via lipogenesis; in the liver, glucose is converted into both. Glucose production and secretion by the liver are strongly inhibited by high concentrations of insulin in the blood. Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is thus an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules in the cells. Low insulin in the blood has the opposite effect, promoting widespread catabolism, especially of reserve body fat. Beta cells are sensitive to blood sugar levels so that they secrete insulin into the blood in response to high level of glucose, and inhibit secretion of insulin when glucose levels are low. Insulin production is also regulated by glucose: high glucose promotes insulin production while low glucose levels lead to lower production. Insulin enhances glucose uptake and metabolism in the cells, thereby reducing blood sugar.
Circumcision is recommended for, but is not required of, converts to Islam. Quranists (less than 1% of all Muslims) reject hadith, and because circumcision is not mentioned in the Quran they do not consider it to be an Islamic practice.
The first refrigerated cars in Japan entered service in 1908, primarily for fish transport. They were of the ReSo 200 type, from 1909, followed by the ReSo 210 type, from 1912, and then the ReSo 230 type; all were reclassified into Re 1 type in 1928. Many of these cars were equipped with ice bunkers, but the bunkers were not generally used. Fish were packed in wooden or foam polystyrene boxes with crushed ice. Transporting fruit, vegetables, and meat in refrigerated rail cars was uncommon in Japan. For fruits and vegetables, ventilated cars were sufficient due to the relatively short distances involved. In contrast, meat, which requires low-temperature storage, was typically transported by ship, as most major Japanese cities are located along the coast. Refrigerator cars suffered heavy damage in World War II. After the war, the occupation forces confiscated many cars for their own use, using the ice bunkers as originally intended. Supplies were landed primarily at Yokohama, and reefer trains ran from the port to U.S. bases around Japan. Around this time, the surviving pre-war refrigerator cars were gradually retired and replaced with newer types. In 1966, JNR developed the ReSa 10000 and ReMuFu 10000 type refrigerated cars that could travel at 100 km/h (62 mph). They were used in fish freight express trains. "Tobiuo" (Flying fish) train from Shimonoseki to Tokyo, and "Ginrin" (Silver scale) train from Hakata to Tokyo, were operated. By the 1960s, refrigerator trucks had begun to displace railcars.
Sources: en.wikipedia.org
Russian novelist Eduard Limonov recounts his personal experience being put under insulin shock therapy in his 1986 novel A Young Scoundrel, scenes from which are adapted for film in the 2004 crime comedy-drama It's Russian.
==== Early infancy ==== Early infancy androgen effects are the least understood. In the first weeks of life for male infants, testosterone levels rise. The levels remain in a pubertal range for a few months, but usually reach the barely detectable levels of childhood by 4–7 months of age. The function of this rise in humans is unknown. One theory holds that brain masculinization is occurring since no significant changes have been identified in other parts of the body. The male brain is masculinized by the aromatization of testosterone into estradiol, which crosses the blood–brain barrier and enters the male brain, whereas female fetuses have α-fetoprotein, which binds the estrogen so that female brains are not affected.
As of 19 September 2026, at least 234 people had been killed (including 17 who are missing and presumed dead) in 78 strikes on 79 vessels, including 15 vessels struck in the Caribbean Sea, 31 in the Eastern Pacific, and 2 in an unspecified location. In four of the strikes as of 31 December 2025, crew members survived the initial strike. The number of people killed includes two survivors from the initial strike who were killed in subsequent strikes and one missing survivor of the 27 October strike who is presumed dead. Two people who survived the 16 October strike were repatriated to their home countries. The US Coast Guard suspended a search for an unknown number of survivors of the 30 December strike. The Department of Defense has not often provided information about what drug cartels have been involved in the vessels targeted for airstrikes, or publicly identified the alleged drug traffickers.
Sources: en.wikipedia.org
== Career and research == Following his PhD, Scrutton was appointed as Lecturer (1995), then Reader (1997) and Professor (1999) at the University of Leicester before being appointed Professor at the University of Manchester in 2005. He has held successive research fellowships over 29 years from the Royal Commission for the Exhibition of 1851 (1851 Research Fellowship), St John's College, Cambridge, the Royal Society (Royal Society University Research Fellow and Royal Society Wolfson Research Merit Award), the Lister Institute of Preventive Medicine, the Biotechnology and Biological Sciences Research Council (BBSRC) and the Engineering and Physical Sciences Research Council (EPSRC). He has been Visiting Professor at Tsinghua University (Beijing, China) and Cardiff University (UK), and adjunct professor at VISTEC (Thailand) and Beijing University of Chemical Technology (China). He has made major contributions to the study of enzyme catalysis, the mechanisms and structures of enzymes and the photochemistry of photoreceptor proteins. His group has investigated quantum tunnelling and protein dynamics in enzyme H-transfer and conformational ensemble sampling in electron transfer reactions. He has also made contributions to enzyme kinetics, coenzyme chemistry, protein engineering, directed evolution, synthetic biology, biological engineering, biocatalysis and metabolic engineering, including the first rational redesign of the coenzyme specificity of an enzyme, the establishment of automated microorganism bioengineering platforms for the production of chemicals (e.g.
== Signs and symptoms == Head pain occurs in 50–75% of all cases of vertebral artery dissection. It tends to be located at the back of the head, either on the affected side or in the middle, and develops gradually. It is either dull or pressure-like in character or throbbing. About half of those with VAD consider the headache distinct, while the remainder have had a similar headache before. It is suspected that VAD with headache as the only symptom is fairly common; 8% of all cases of vertebral and carotid dissection are diagnosed on the basis of pain alone. Obstruction of blood flow through the affected vessel may lead to dysfunction of part of the brain supplied by the artery. This happens in 77–96% of cases. This may be temporary ("transient ischemic attack") in 10–16% of cases, but many (67–85% of cases) end up with a permanent deficit or a stroke. The vertebral artery supplies the part of the brain that lies in the posterior fossa of the skull, and this type of stroke is therefore called a posterior circulation infarct. Problems may include difficulty speaking or swallowing (lateral medullary syndrome); this occurs in less than a fifth of cases and occurs due to dysfunction of the brainstem. Others may experience unsteadiness or lack of coordination due to involvement of the cerebellum, and still others may develop visual loss (on one side of the visual field) due to involvement of the visual cortex in the occipital lobe.
Homocysteine levels typically are higher in men than women, and increase with age. Common levels in Western populations are 10 to 12 μmol/L, and levels of 20 μmol/L are found in populations with low B-vitamin intakes or in the elderly (e.g., Rotterdam, Framingham). It is decreased with methyl folate trapping, where it is accompanied by decreased methylmalonic acid, increased folate, and a decrease in formiminoglutamic acid. This is the opposite of MTHFR C677T mutations, which result in an increase in homocysteine.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.